4/15
08:11 am
indp
Indaptus Therapeutics, Inc. (NASDAQ: INDP) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $12.00 price target on the stock.
Medium
Report
Indaptus Therapeutics, Inc. (NASDAQ: INDP) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $12.00 price target on the stock.
4/11
07:40 am
indp
Indaptus Therapeutics Presents Positive Mechanism of Action Data at the American Association for Cancer Research Annual Meeting [Yahoo! Finance]
High
Report
Indaptus Therapeutics Presents Positive Mechanism of Action Data at the American Association for Cancer Research Annual Meeting [Yahoo! Finance]
4/11
07:30 am
indp
Indaptus Therapeutics Presents Positive Mechanism of Action Data at the American Association for Cancer Research Annual Meeting
Medium
Report
Indaptus Therapeutics Presents Positive Mechanism of Action Data at the American Association for Cancer Research Annual Meeting
3/28
08:00 am
indp
Indaptus Therapeutics to Present at the MedInvest Biotech and Pharma Investor Conference
Medium
Report
Indaptus Therapeutics to Present at the MedInvest Biotech and Pharma Investor Conference
3/27
08:53 am
indp
Is Indaptus Therapeutics (NASDAQ:INDP) In A Good Position To Invest In Growth? [Yahoo! Finance]
High
Report
Is Indaptus Therapeutics (NASDAQ:INDP) In A Good Position To Invest In Growth? [Yahoo! Finance]
3/25
08:44 am
indp
Indaptus Therapeutics Previews Positive Mechanism of Action Data to be Presented at the American Association for Cancer Research Annual Meeting [Yahoo! Finance]
Medium
Report
Indaptus Therapeutics Previews Positive Mechanism of Action Data to be Presented at the American Association for Cancer Research Annual Meeting [Yahoo! Finance]
3/25
08:30 am
indp
Indaptus Therapeutics Previews Positive Mechanism of Action Data to be Presented at the American Association for Cancer Research Annual Meeting
Medium
Report
Indaptus Therapeutics Previews Positive Mechanism of Action Data to be Presented at the American Association for Cancer Research Annual Meeting
3/18
08:17 am
indp
Indaptus Therapeutics to Participate in Tribe Public Webinar On Wednesday, March 20, 2024 [Yahoo! Finance]
Medium
Report
Indaptus Therapeutics to Participate in Tribe Public Webinar On Wednesday, March 20, 2024 [Yahoo! Finance]
3/18
08:00 am
indp
Indaptus Therapeutics to Participate in Tribe Public Webinar On Wednesday, March 20, 2024
High
Report
Indaptus Therapeutics to Participate in Tribe Public Webinar On Wednesday, March 20, 2024
3/13
07:52 am
indp
Indaptus Therapeutics Reports Fourth Quarter and Year-End 2023 Financial Results and Provides Corporate Update [Yahoo! Finance]
Medium
Report
Indaptus Therapeutics Reports Fourth Quarter and Year-End 2023 Financial Results and Provides Corporate Update [Yahoo! Finance]
3/13
07:30 am
indp
Indaptus Therapeutics Reports Fourth Quarter and Year-End 2023 Financial Results and Provides Corporate Update
Medium
Report
Indaptus Therapeutics Reports Fourth Quarter and Year-End 2023 Financial Results and Provides Corporate Update
3/4
07:30 am
indp
Indaptus Therapeutics Announces Positive Results from Second Cohort of Phase 1 Trial; Company Initiates Multi-Dose Cohort
Medium
Report
Indaptus Therapeutics Announces Positive Results from Second Cohort of Phase 1 Trial; Company Initiates Multi-Dose Cohort
2/15
08:00 am
indp
Indaptus Therapeutics to Present at the 2024 BIO CEO & Investor Conference
Medium
Report
Indaptus Therapeutics to Present at the 2024 BIO CEO & Investor Conference
2/8
08:00 am
indp
Indaptus Therapeutics Expands Digital Presence with Launch of Social Media Channels
Low
Report
Indaptus Therapeutics Expands Digital Presence with Launch of Social Media Channels